After months of promises by Medtronic, the FDA finally gave approval to market in the U.S the company’s Revo MRI SureScan pacer. Patients implanted with pacemakers sometime require radiological imaging with MRI for related and unrelated reasons, such as rotator cuff tears and such, so the recent development of MRI compatible cardiac implants should be a major help in managing these patients. MR-Conditional refers to the idea that to be used safely in an MRI machine, a set of specific conditions have to be met regarding the nature and settings of the magnet.
Some features of the Revo MRI SureScan from the product page:
Managed Ventricular Pacing (MVP®) promotes intrinsic conduction and reduces unnecessary right ventricular pacing by 99%6 Cardiac Compass® graphically displays more than a year of trended data to help monitor and manage AF and AT Reactive ATP™ (Antitachycardia Pacing) continuously monitors and responds to changes in rate or regularity of AT episodes, and appropriately delivers atrial ATP therapies to restore sinus rhythm
Press release: Medtronic Receives FDA Approval for First and Only Pacemaker System in the U.S. Designed for Use in the MRI Environment
Product page: Revo MRI SureScan Pacing System
Medgadget’s MRI pacemaker flashbacks…
Update: Thanks to reader Tobias for the correction regarding MRI Safe vs MR-Conditional pacers.